---
title: "Alpha Cognition Inc. Announces NMPA Acceptance of ZUNVEYL NDA for Alzheimer's Treatment in China"
description: "Alpha Cognition Inc. announced that its partner, China Medical System Holdings Limited, has received acceptance for their New Drug Application (NDA) for ZUNVEYL® (Benzgalantamine) by the National Medi"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/250599091.md"
published_at: "2025-07-29T12:31:03.000Z"
---

# Alpha Cognition Inc. Announces NMPA Acceptance of ZUNVEYL NDA for Alzheimer's Treatment in China

> Alpha Cognition Inc. announced that its partner, China Medical System Holdings Limited, has received acceptance for their New Drug Application (NDA) for ZUNVEYL® (Benzgalantamine) by the National Medical Products Administration of China. This treatment targets mild-to-moderate Alzheimer’s dementia and marks a significant step towards introducing it to the Asian market. Alpha Cognition will benefit from CMS’s expertise and receive financial gains upon ZUNVEYL’s approval for marketing in China and other Asian territories.

Alpha Cognition Inc., a biopharmaceutical company specializing in therapies for neurodegenerative disorders, announced that their partner, China Medical System Holdings Limited (CMS), has received acceptance for their New Drug Application (NDA) by the National Medical Products Administration of China (NMPA). This NDA pertains to ZUNVEYL® (Benzgalantamine), a treatment aimed at mild-to-moderate Alzheimer’s dementia. This milestone signifies a critical step toward potentially introducing this innovative therapy to the Asian market. Alpha Cognition is set to benefit from CMS’s regulatory and commercial expertise in China and will receive financial gains such as regulatory and sales milestones, and royalties upon ZUNVEYL’s approval for marketing in China and other Asian territories. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alpha Cognition Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250729192664) on July 29, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)

### Related Stocks

- [ACOG.US - Alpha Cognition](https://longbridge.com/en/quote/ACOG.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Opaleye Management Inc. 提交了 Alpha Cognition 的初始实益所有权声明 | Alpha Cognition Inc. 已提交了一份初步的受益所有权声明，确认 Opaleye Management Inc. 为受益所有者。完整的文件可以通过提供的链接访问。此新闻简报由公共技术公司（PUBT）使用人工智能生成，仅供信息 | [Link](https://longbridge.com/en/news/276485862.md) |
| 沃尔玛四季度财报超预期但盈利指引不及预期，CEO 称 “美国低收入家庭只能勉强维持生计” | 沃尔玛 Q4 营收超预期，新财年盈利指引（每股 2.75-2.85 美元）远低于市场预期的 2.96 美元，显示通胀压力下消费者支出不确定性犹存，拖累股价下跌 1.38%。财报印证 K 型” 分化：高收入家庭驱动增长，低收入群体 “钱包吃紧 | [Link](https://longbridge.com/en/news/276398633.md) |
| 谷歌突然发布 Gemini 3.1 Pro：核心推理性能直接翻倍 | 谷歌发布了最新的大模型 Gemini 3.1 Pro，其推理性能较去年发布的 Gemini 3 Pro 翻倍。在 ARC-AGI-2 评测中，Gemini 3.1 Pro 得分 77.1%，显示出强大的推理能力。新模型支持多源数据综合和复杂 | [Link](https://longbridge.com/en/news/276396515.md) |
| 学习英伟达刺激芯片销售，AMD 为 “AI 云” 借款做担保 | AMD 为扩大市场份额祭出金融 “狠招”！为初创公司 Crusoe 的 3 亿美元购芯贷款提供担保，承诺在其无客户时 “兜底” 租用芯片。这一复刻英伟达 “租卡云” 路径的策略虽能短期推高销量，但也令 AMD 在 AI 需求放缓时面临更大的 | [Link](https://longbridge.com/en/news/276401504.md) |
| 最高法裁决后特朗普动用替补选择：加征 10% 全球关税 | 美国总统特朗普在最高法院裁决后宣布将加征 10% 的全球关税，以补救被推翻的关税措施。根据《1974 年贸易法》第 122 条款，现有的关税将全面生效。最高法院裁定特朗普政府的部分关税措施缺乏法律授权。市场风险提示，投资需谨慎。 | [Link](https://longbridge.com/en/news/276477629.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.